Key result
Quantitative 2-D echocardiography differentiates HCM from hypertensive heart disease with 93% specificity.
Why the study?
Differentiating hypertrophic cardiomyopathy from hypertensive heart disease is a diagnostic challenge, and M-mode echocardiography only assesses hypertrophy in limited areas.
Does quantitative 2-D echocardiography accurately differentiate hypertrophic cardiomyopathy from hypertensive heart disease with severe cardiac hypertrophy?
Cross-Sectional (n=60)
Does quantitative 2-D echocardiography accurately differentiate hypertrophic cardiomyopathy from hypertensive heart disease with severe cardiac hypertrophy?
Quantitative 2-D echocardiography provides high specificity for differentiating hypertrophic cardiomyopathy from hypertensive heart disease, overcoming the limitations of conventional M-mode criteria.
No takes yet. Share an insight, caveat, or question.
May aid ruling out in suspected cases; leaves open validation in larger prospective cohorts.
Keller et al. (1990) conducted a cross-sectional in Hypertrophic cardiomyopathy and hypertensive heart disease (n=60). Quantitative 2-D echocardiography vs. Conventional M-mode echocardiography was evaluated on Diagnostic sensitivity and specificity of combined 2-D echocardiographic criteria (cross-sectional area >21 cm2m-2 and septal segment >6.5 cm2m-2). Quantitative 2-D echocardiography using combined criteria differentiated hypertrophic cardiomyopathy from hypertensive heart disease with 77% sensitivity and 93% specificity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: